Grantham, Mayo, Van Otterloo & Co (GMO)’s Sandy Spring Bancorp Inc SASR Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SASR Stock Details SASR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-35,815	Closed	-$1M	–	705
2025 Q1	$1M	Buy	+35,815	New	+$1.14M	﹤0.01%	458
2021 Q2	–	Sell	-11,900	Closed	-$517K	–	870
2021 Q1	$517K	Hold	11,900	–	–	﹤0.01%	693
2020 Q4	$383K	Sell	11,900 -6,100	-34%	-$174K	﹤0.01%	719
2020 Q3	$415K	Buy	+18,000	New	+$425K	﹤0.01%	650
2020 Q2	–	Sell	-27,200	Closed	-$616K	–	840
2020 Q1	$616K	Sell	27,200 -65,300	-71%	-$2.08M	0.01%	566
2019 Q4	$3.5M	Sell	92,500 -2,800	-3%	-$98.7K	0.02%	334
2019 Q3	$3.21M	Buy	95,300 +85,900	+914%	+$2.98M	0.02%	355
2019 Q2	$328K	Buy	+9,400	New	+$316K	﹤0.01%	648

Other funds holding SASR

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SASR Position: Q2 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Sandy Spring Bancorp Inc (SASR) in Q2 2025, closing a stake of 35,815 shares — an estimated $1M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SASR in Q2 2019 and held it in 8 quarters. The position peaked at $3.5M in Q4 2019. 2 funds tracked by Wall St. Rank hold SASR as of Q2 2025.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Sandy Spring Bancorp Inc position as of Q2 2025 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 35,815 Sandy Spring Bancorp Inc shares in Q2 2025, an estimated $1M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Sandy Spring Bancorp Inc in Q2 2019 and held it in 8 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Sandy Spring Bancorp Inc position peaked at $3.5M in Q4 2019.
2 funds tracked by Wall St. Rank held Sandy Spring Bancorp Inc as of Q2 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2025, filed 13 Aug 2025.